Advances in animal cell recombinant protein production: GS-NS0 expression system
暂无分享,去创建一个
[1] J. Trowsdale,et al. The LFA‐3 Adhesion Pathway is Differently Utilized by Superantigen‐Activated Human CD4+ T‐Cell Subsets , 1992, Scandinavian journal of immunology.
[2] P. Tsai,et al. Product Consistency During Long-Term Fed-Batch Culture , 1994 .
[3] M. Cockett,et al. The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines. , 1991, Nucleic acids research.
[4] R. Owens,et al. Expression, purification and characterization of B72.3 Fv fragments. , 1993, The Biochemical journal.
[5] E. Garvey,et al. High-level expression of human inducible nitric oxide synthase in Chinese hamster ovary cells and characterization of the purified enzyme. , 1996, Biochemical and biophysical research communications.
[6] M J Keen,et al. Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. , 1995, Glycobiology.
[7] R. Dwek,et al. Site-specific glycosylation of recombinant rat and human soluble CD4 variants expressed in Chinese hamster ovary cells. , 1993, The Journal of biological chemistry.
[8] Zhong Liu,et al. Rapid establishment of high-producing cell lines using dicistronic vectors with glutamine synthetase as the selection marker , 1998, Molecular biotechnology.
[9] J. O'Connell,et al. The role of the C-terminal domain in collagenase and stromelysin specificity. , 1992, The Journal of biological chemistry.
[10] Brown Mh,et al. Expression of immunoglobulin and scavenger receptor superfamily domains as chimeric proteins with domains 3 and 4 of CD4 for ligand analysis , 1994 .
[11] A. Cloeckaert,et al. Characterization of O-polysaccharide specific monoclonal antibodies derived from mice infected with the rough Brucella melitensis strain B115. , 1993, Journal of general microbiology.
[12] M. Glennie,et al. Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma. , 1995, Journal of immunology.
[13] D K Robinson,et al. Characterization of a recombinant antibody produced in the course of a high yield fed‐batch process , 1994, Biotechnology and bioengineering.
[14] N. Hogg,et al. Antibodies that activate β2 integrins can generate different ligand binding states , 1995, European journal of immunology.
[15] F. Jakob,et al. Characterization of five monoclonal antibodies raised against domain E of the porcine estradiol receptor. , 2009, Experimental and clinical endocrinology.
[16] A. Cloeckaert,et al. O-chain expression in the rough Brucella melitensis strain B115: induction of O-polysaccharide-specific monoclonal antibodies and intracellular localization demonstrated by immunoelectron microscopy. , 1992, Journal of general microbiology.
[17] S. Latt,et al. Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells , 1985, Molecular and cellular biology.
[18] C. Simonsen,et al. The molecular biology of production cell lines. , 1994, Biologicals : journal of the International Association of Biological Standardization.
[19] R. Field,et al. Selecting and designing cell lines for improved physiological characteristics , 2004, Cytotechnology.
[20] P. Bjorkman,et al. Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[21] D. Stuart,et al. Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2. , 1993, Protein engineering.
[22] C. Milstein,et al. Possible role for the Fc receptor on B lymphocytes , 1974, Nature.
[23] P. Johnson,et al. Structure and function of CD45: a leukocyte-specific protein tyrosine phosphatase. , 1992, Advances in experimental medicine and biology.
[24] J. Moore,et al. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4. , 1990, AIDS.
[25] R. L. Hawkins,et al. Lactate: A major product of glutamine metabolism by human diploid fibroblasts , 1980, Journal of cellular physiology.
[26] N. Proudfoot. Transcriptional interference and termination between duplicated α-globin gene constructs suggests a novel mechanism for gene regulation , 1986, Nature.
[27] M. Doyle,et al. THE DEVELOPMENT OF A PROCESS FOR THE PRODUCTION OF HIV1 GP120 FROM RECOMBINANT CELL LINES , 1991 .
[28] C. Bebbington,et al. Control of growth and recombinant protein synthesis by heat-shock in a mutant mammalian cell line , 1994, Biotechnology Letters.
[29] L. Levintow,et al. Reversibility of the enzymatic synthesis of glutamine. , 1954, The Journal of biological chemistry.
[30] M. Massaer,et al. Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells. , 1996, Virus research.
[31] B. Buckland,et al. Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production. , 1997, Biotechnology and bioengineering.
[32] J. Wienberg,et al. Amplified expression constructs for human tissue-type plasminogen activator in Chinese hamster ovary cells: instability in the absence of selective pressure. , 1988, Gene.
[33] D R Burton,et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. , 1994, Science.
[34] S. Nussey,et al. The use of the amplifiable high-expression vector pEE14 to study the interactions of autoantibodies with recombinant human thyrotrophin receptor , 1992, Molecular and Cellular Endocrinology.
[35] J. F. Speck. The enzymic synthesis of glutamine. , 1947, The Journal of biological chemistry.
[36] J. Kearney,et al. Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein , 1987, The Journal of cell biology.
[37] D. James,et al. Real-time monitoring of recombinant protein concentration in animal cell cultures using an optical biosensor , 1997 .
[38] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[39] A. Barclay,et al. The hinge region of the CD8 alpha chain: structure, antigenicity, and utility in expression of immunoglobulin superfamily domains. , 1992, International immunology.
[40] J. Cyster,et al. The NH2‐terminal domain of rat CD2 binds rat CD48 with a low affinity and binding does not require glycosylation of CD2 , 1993, European journal of immunology.
[41] M. Silberklang,et al. Structural characterization of the N-glycans of a humanized anti-CD18 murine immunoglobulin G. , 1994, Archives of biochemistry and biophysics.
[42] R. Owens,et al. Interaction of the low-affinity receptor CD23/Fc epsilonRII lectin domain with the Fc epsilon3-4 fragment of human immunoglobulin E. , 1997, Biochemistry.
[43] A. Meister. 23. Glutamine Synthetase of Mammals , 1974 .
[44] P. Slocombe,et al. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. , 1993, Biochemistry.
[45] C. Milstein,et al. Fusion between immunoglobulin‐secreting and nonsecreting myeloma cell lines , 1976, European journal of immunology.
[46] G. Moore,et al. The effect of dihydrofolate reductase-mediated gene amplification on the expression of transfected immunoglobulin genes. , 1987, Journal of immunology.
[47] H. Pu,et al. The structure of the chicken glutamine synthetase-encoding gene. , 1989, Gene.
[48] S. Nussey,et al. Interaction of thyrotropin and thyroid-stimulating antibodies with recombinant extracellular region of human TSH receptor , 1992, The Lancet.
[49] M. Silberklang,et al. Optimization of a Fed‐batch Process for Production of a Recombinant Antibody , 1994, Annals of the New York Academy of Sciences.
[50] E. Padlan,et al. A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties. , 1997, AIDS research and human retroviruses.
[51] W. Zhang,et al. Identification of functional domains on gC1Q-R, a cell surface protein that binds to the globular "heads" of C1Q, using monoclonal antibodies and synthetic peptides. , 1996, Hybridoma.
[52] R. Owens,et al. Secretion of recombinant human IgE-Fc by mammalian cells and biological activity of glycosylation site mutants. , 1995, Protein engineering.
[53] E. Butcher,et al. Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events. , 1992, Journal of immunology.
[54] T. Deuel,et al. Regulation of glutamine synthetase by dexamethasone in hepatoma tissue culture cells. , 1978, The Journal of biological chemistry.
[55] R. Field,et al. Process development for the production of recombinant antibodies using the glutamine synthetase (GS) system , 2006, Cytotechnology.
[56] P. Bjorkman,et al. Effects of peptide length and composition on binding to an empty class I MHC heterodimer. , 1994, Biochemistry.
[57] A. F. Williams,et al. Structural diversity in domains of the immunoglobulin superfamily. , 1989, Cold Spring Harbor symposia on quantitative biology.
[58] A. Meister. 1 – Catalytic Mechanism of Glutamine Synthetase; Overview of Glutamine Metabolism , 1980 .
[59] H. Wong,et al. Single-chain MHC class II molecules induce T cell activation and apoptosis. , 1996, Journal of immunology.
[60] L. Cavaleri,et al. Purification and properties of insulin receptor ectodomain from large-scale mammalian cell culture. , 1995, Protein expression and purification.
[61] M. Butler,et al. Nutritional aspects of the growth of animal cells in culture , 1989 .
[62] M. Potter,et al. Induction of Plasma-Cell Neoplasms in Strain BALB/c Mice with Mineral Oil and Mineral Oil Adjuvants , 1962, Nature.
[63] T. Kadesch,et al. Effects of the position of the simian virus 40 enhancer on expression of multiple transcription units in a single plasmid , 1986, Molecular and cellular biology.
[64] N. Jenkins,et al. Generation of CHO Cell Mutants for Growth Control , 1993 .
[65] B. Davis,et al. NMR analysis of the N-terminal SRCR domain of human CD5: engineering of a glycoprotein for superior characteristics in NMR experiments. , 1998, Protein engineering.
[66] M. Potter,et al. HISTOLOGY OF DEVELOPING PLASMA CELL NEOPLASIA INDUCED BY MINERAL OIL IN BALB/C MICE. , 1964, Journal of the National Cancer Institute.
[67] C. McInnes,et al. The cloning and expression of the gene for ovine interleukin-3 (multi-CSF) and a comparison of the in vitro hematopoietic activity of ovine IL-3 with ovine GM-CSF and human M-CSF. , 1993, Experimental hematology.
[68] E. Appella,et al. Variations in the heavy polypeptide chain structure of gamma myeloma immunoglobulins from an inbred strain of mice and a hypothesis as to their origin. , 1965, Journal of molecular biology.
[69] M. Zhu,et al. Immunoglobulin variable region hypermutation in hybrids derived from a pre-B- and a myeloma cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[70] D. Gewert,et al. Expression and purification of recombinant, glycosylated human interferon alpha 2b in murine myeloma NSo cells. , 1996, Protein expression and purification.
[71] K. Gull,et al. NSO myeloma cell death: Influence of bcl‐2 overexpression , 1996, Biotechnology and bioengineering.
[72] E. Berg,et al. Antibodies cross-reactive with E- and P-selectin block both E- and P-selectin functions. , 1995, Blood.
[73] W. H. Elliott. Adenosinetriphosphate in Glutamine Synthesis , 1948, Nature.
[74] R. Miller,et al. Regulation of glutamine synthetase in cultured 3T3-L1 cells by insulin, hydrocortisone, and dibutyryl cyclic AMP. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[75] M. Lockyer,et al. A humanized CD18 antibody can block function without cell destruction. , 1993, Journal of Immunology.
[76] E. Carafoli,et al. Isolation and Characterization of a Stable Chinese Hamster Ovary Cell Line Overexpressing the Plasma Membrane Ca2+-ATPase (*) , 1995, The Journal of Biological Chemistry.
[77] C. Milstein,et al. [1] Preparation of monoclonal antibodies: Strategies and procedures , 1981 .
[78] A. Johnstone,et al. Characterization of the glutamine synthetase amplifiable eukaryotic expression system applied to an integral membrane protein--the human thyrotropin receptor. , 1992, Analytical biochemistry.
[79] R. Kucherlapati,et al. Introduction of purified genes into mammalian cells. , 1984, CRC critical reviews in biochemistry.
[80] R. Field,et al. The Production of Recombinant Antibodies Using the Glutamine Synthetase (GS) System , 1993 .
[81] M. Castro,et al. Effect of the corticotrophin releasing hormone precursor on interleukin-6 release by human mononuclear cells. , 1997, Clinical immunology and immunopathology.
[82] N. Jenkins,et al. Temperature control of growth and productivity in mutant Chinese hamster ovary cells synthesizing a recombinant protein , 1993, Biotechnology and bioengineering.
[83] R. Williamson,et al. Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13. , 1992, Biochemistry.
[84] M. Feany,et al. The synaptic vesicle proteins SV2, synaptotagmin and synaptophysin are sorted to separate cellular compartments in CHO fibroblasts , 1993, The Journal of cell biology.
[85] G. Murshudov,et al. Crystal structure of an extracellular fragment of the rat CD4 receptor containing domains 3 and 4. , 1994, Structure.
[86] S. Gloor,et al. Production and secretion in CHO cells of the extracellular domain of AMOG/beta 2, a type-II membrane protein. , 1992, Gene.
[87] S. Nussey,et al. Characterization of the extracellular region of the human thyrotrophin receptor expressed as a recombinant protein. , 1992, Journal of molecular endocrinology.
[88] A. Nesbitt,et al. Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses. , 1995, Immunology.
[89] A R Flesher,et al. Fluorophore‐labeled carbohydrate analysis of immunoglobulin fusion proteins: Correlation of oligosaccharide content with in vivo clearance profile , 1995, Biotechnology and bioengineering.
[90] M. Cockett,et al. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. , 1992, The Biochemical journal.
[91] M. Page. Expression of foreign genes in Mammalian cells. , 1988, Methods in molecular biology.
[92] A. Tsarbopoulos,et al. Expression, Purification, and Characterization of Recombinant Human Interleukin-13 from NS-0 Cells☆ , 1998 .
[93] N. G. Ray,et al. Large-Scale Production of Humanized Monoclonal Antibody Expressed in a GS-NSO Cell Line , 1997 .
[94] E. M. Tucker,et al. The production of equine monoclonal immunoglobulins by horse-mouse heterohybridomas. , 1992, Veterinary immunology and immunopathology.
[95] N. Hogg,et al. The I Domain of Integrin LFA-1 Interacts with ICAM-1 Domain 1 at Residue Glu-34 but Not Gln-73* , 1998, The Journal of Biological Chemistry.
[96] C. Bebbington,et al. Expression of antibody genes in nonlymphoid mammalian cells , 1991 .
[97] B. Buckland,et al. Monoclonal Antibody Process Development Using Medium Concentrates , 1994, Biotechnology progress.
[98] D. Shotton,et al. Structural analysis of the CD5 antigen--expression, disulphide bond analysis and physical characterisation of CD5 scavenger receptor superfamily domain 1. , 1998, European journal of biochemistry.
[99] M. J. Keen,et al. Adaptation of cholesterol-requiring NS0 mouse myeloma cells to high density growth in a fully defined protein-free and cholesterol-free culture medium , 1995, Cytotechnology.
[100] J. Gray,et al. Effects of methotrexate on transfected DNA stability in mammalian cells , 1990, Molecular and cellular biology.
[101] J. Hodgson. Expression Systems: A User's Guide , 1993, Bio/Technology.
[102] Y. Henis,et al. Effects of exposure to low pH on the lateral mobility of influenza hemagglutinin expressed at the cell surface: correlation between mobility inhibition and inactivation. , 1993, Biochemistry.
[103] H. Marsden,et al. Production and characterization of monoclonal antibodies to cervine herpesvirus-1. , 1992, Veterinary microbiology.
[104] W. Harris,et al. A humanized antibody against human cytomegalovirus (CMV) gpUL75 (gH) for prophylaxis or treatment of CMV infections. , 1997, The Journal of infectious diseases.
[105] B. Olsen,et al. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. , 1996, The Journal of biological chemistry.
[106] S. R. Max,et al. Glutamine regulates glutamine synthetase expression in skeletal muscle cells in culture , 1990, Journal of cellular physiology.
[107] William Arbuthnot Sir Lane,et al. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. , 1995, Immunity.
[108] B. Buckland,et al. Investigation of NS0 Cell Metabolic Behavior in Monoclonal Antibody Producing Clones , 1994, Annals of the New York Academy of Sciences.
[109] F. Hirayama,et al. Synergistic interaction between interleukin-12 and steel factor in support of proliferation of murine lymphohematopoietic progenitors in culture. , 1994, Blood.
[110] D. Pfarr,et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. , 1997, The Journal of infectious diseases.
[111] C. Milstein,et al. Intracellular immunoglobulin chain synthesis in non-secreting variants of a mouse myeloma: detection of inactive light-chain messenger RNA. , 1974, Journal of molecular biology.
[112] C. Milstein,et al. Preparation of monoclonal antibodies: strategies and procedures. , 1981, Methods in enzymology.
[113] W. H. Elliott. Studies on the enzymic synthesis of glutamine. , 1951, The Biochemical journal.
[114] R. Owens,et al. Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy. , 1995, British Journal of Cancer.
[115] M. Cockett,et al. High Level Expression of Tissue Inhibitor of Metalloproteinases in Chinese Hamster Ovary Cells Using Glutamine Synthetase Gene Amplification , 1990, Bio/Technology.
[116] P. Roughley,et al. Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. , 1993, The Biochemical journal.
[117] M. Page,et al. High Level Expression of the Humanized Monoclonal Antibody CAMPATH-1H in Chinese Hamster Ovary Cells , 1991, Bio/Technology.
[118] J. Innes,et al. Variation in IgG1 heavy chain allotype does not contribute to differences in biological activity of two human anti-Rhesus (D) monoclonal antibodies. , 1998, Immunotechnology : an international journal of immunological engineering.
[119] L. Reitzer,et al. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.
[120] M. Cockett,et al. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). , 1991, The Biochemical journal.
[121] Y. Henis,et al. GPI- and transmembrane-anchored influenza hemagglutinin differ in structure and receptor binding activity , 1993, The Journal of cell biology.
[122] N. Siemers,et al. Construction, expression, and activities of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation. , 1997, Bioconjugate chemistry.
[123] K B Konstantinov,et al. Monitoring and control of the physiological state of cell cultures. , 2000, Biotechnology and bioengineering.
[124] M. Rhodes,et al. Production of recombinant proteins in serum-free media , 2004, Cytotechnology.
[125] W. Wooster,et al. Crystal structure of , 2005 .
[126] M. J. Keen,et al. The use of serum-free medium for the production of functionally active humanised monoclonal antibody from NS0 mouse myeloma cells engineered using glutamine synthetase as a selectable marker , 2004, Cytotechnology.
[127] D. King,et al. High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker , 1992, Bio/Technology.
[128] A. Persson,et al. Recombinant pulmonary surfactant protein D. Post-translational modification and molecular assembly. , 1994, The Journal of biological chemistry.
[129] A. Meister,et al. Studies on the mechanism of inhibition of glutamine synthetase by methionine sulfoximine. , 1969, Biochemistry.
[130] S. Mercille,et al. Induction of apoptosis in oxygen-deprived cultures of hybridoma cells , 1994 .
[131] P. Tomasec,et al. Expression of Biologically Active Procorticotrophin‐Releasing Hormone (proCRH) in Stably Transfected CHO‐K1 Cells: Characterization of Nuclear proCRH , 1995, Journal of neuroendocrinology.
[132] D. Shotton,et al. Expression of soluble isoforms of rat CD45. Analysis by electron microscopy and use in epitope mapping of anti-CD45R monoclonal antibodies. , 1992, Immunology.
[133] A. Meister,et al. Inhibition of glutamine synthetase by methionine sulfoximine. Studies on methionine sulfoximine phosphate. , 1969, Biochemistry.
[134] C. Milstein,et al. Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusion , 1976, European journal of immunology.
[135] A. Meister,et al. Identification of L-methionine S-sulfoximine as the diastereoisomer of L-methionine SR-sulfoximine that inhibits glutamine synthetase. , 1969, Biochemistry.
[136] Weichang Zhou,et al. Large scale production of recombinant mouse and rat growth hormone by fed-batch GS-NSO cell cultures , 2004, Cytotechnology.
[137] A. W. Harris,et al. Mouse myelomas and lymphomas in culture. , 1970, Experimental cell research.
[138] T. Lee,et al. Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells. , 1997, Gene.
[139] I. A. Rose,et al. A stereochemical method for detection of ATP terminal phosphate transfer in enzymatic reactions. Glutamine synthetase. , 1976, The Journal of biological chemistry.
[140] S. Prusiner,et al. Prion protein expression in Chinese hamster ovary cells using a glutamine synthetase selection and amplification system. , 1997, Protein engineering.
[141] P. Tomasec,et al. Mitogenic effects and nuclear localisation of procorticotrophin-releasing hormone expressed within stably transfected fibroblast cells (CHO-K1) , 1995, Molecular and Cellular Endocrinology.
[142] L. Callegaro,et al. Production of novel monoclonal antibodies against rabbit platelet factor four. , 1992, Hybridoma.
[143] L. Chasin,et al. Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[144] W. Farrell,et al. Endoplasmic reticulum protein expression in recombinant NS0 myelomas grown in batch culture. , 2000, Biotechnology and bioengineering.
[145] J. F. Speck. The enzymatic synthesis of glutamine, a reaction utilizing adenosine triphosphate. , 1949, The Journal of biological chemistry.
[146] T. Nakaki,et al. Enhanced transcription of the 78,000-dalton glucose-regulated protein (GRP78) gene and association of GRP78 with immunoglobulin light chains in a nonsecreting B-cell myeloma line (NS-1) , 1989, Molecular and cellular biology.
[147] R. Lechler,et al. Use of a murine T-cell hybridoma expressing human T-cell receptor α- and β-gene products as a tool for the production of human T-cell receptor-specific monoclonal antibodies , 1992 .
[148] A. Barclay,et al. High level expression in Chinese hamster ovary cells of soluble forms of CD4 T lymphocyte glycoprotein including glycosylation variants. , 1990, The Journal of biological chemistry.
[149] C. López-Otín,et al. Biochemical Characterization of Human Collagenase-3 (*) , 1996, The Journal of Biological Chemistry.
[150] K. Elkon,et al. Separate Domains of the Human Fas Ligand Dictate Self-association and Receptor Binding* , 1997, The Journal of Biological Chemistry.
[151] B. Classon,et al. Biochemical and immunological properties of rat recombinant interleukin-2 and interleukin-4. , 1992, Immunology.
[152] S. Narula,et al. Characterization of Recombinant Extracellular Domain of Human Interleukin-10 Receptor (*) , 1995, The Journal of Biological Chemistry.
[153] Hans Marquardt,et al. βig-h3: A Transforming Growth Factor-β-Responsive Gene Encoding a Secreted Protein That Inhibits Cell Attachment In Vitro and Suppresses the Growth of CHO Cells in Nude Mice , 1994 .
[154] A. Meister,et al. Phosphorylation of methionine sulfoximine by glutamine synthetase. , 1968, Proceedings of the National Academy of Sciences of the United States of America.
[155] R. Williamson,et al. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. , 1991, Biochemistry.
[156] D. Robinson,et al. Feeding of nutrients delays apoptotic death in fed-batch cultures of recombinant NSO myeloma cells , 1996, Biotechnology Letters.